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1. Introduction 
The application of modern molecular biology and immunological techniques exponentially 
increased the utilization of liver biopsy material collected from either patients or animal 
models for diagnostic and research purposes. In the areas of our direct research interest, 
which is focused on delineation of the molecular immunopathogenesis of hepatocellular 
injury in hepatitis B virus (HBV) infection and hepadnaviral persistence, the mechanisms of 
hepadnaviral infection of the immune system and elucidation of the hepatocyte immune 
effector function, we routinely investigate liver biopsy specimens obtained from 
woodchucks infected with woodchuck hepatitis virus (WHV). The woodchuck-WHV 
infection system is not only the closest natural animal model of hepatitis B and HBV-
induced hepatocellular carcinoma (HCC), but also is unparalleled for the evaluation of 
novel therapeutic and preventive strategies against HBV and its long-term pathological 
outcomes, such as chronic hepatitis (CH) and HCC.  
The aim of this chapter is to review the findings from investigations of liver biopsy material 
acquired from the woodchuck model of hepatitis B, as well as primary or cultured 
hepatocytes derived from WHV-infected and healthy animals. Since some research areas in 
which the woodchuck model is applied are almost exclusive domains of this laboratory, we 
will describe these areas in more detail. 
1.1 HBV and its pathological significance   
Despite the availability of effective prophylactic vaccines, HBV occurs in an estimated 400 
million people worldwide as a serologically evident chronic infection (Lia & Liaw, 2010; 
Liaw et al., 2010; Romano et al., 2011). Many of these individuals succumb after years of CH 
to liver failure due to cirrhosis and development of HCC. Recent statistics indicate that up to 
one-third of the global population has evidence of exposure to HBV (WHO, 2008). This may 
indicate that over 90% of those exposed carry HBV asymptomatically, at levels which are 
not readily detectable by the current clinical laboratory tests, but which can be often 
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identified by analysis of appropriately prepared samples using research assays of greater 
sensitivity. This has potential implications for blood transfusion, transplantation, as well as 
therapy with immunosuppressive and anti-cancerous toxic agents which reactivate silently 
persisting infection (Feray et al., 1990; Chazouilleres et al., 1994; Dickson et al., 1997; 
Yotsuyanagi et al., 1998; Grob et al., 2000; Carpenter et al., 2002; Hu, 2002; Yuki et al., 2003; 
Pollicino et al., 2004; Mulrooney-Cousins & Michalak, 2007; Kao, 2008; De Mitri et al., 2010; 
Coffin et al., 2011a, 2011b; Morisco et al., 2011; Villadolid et al., 2011).  
HBV is a circular 3.2 kilobase-long, partially double-stranded DNA virus whose genome 
contains four overlapping open reading frames (ORF) named surface (S), core (C), 
polymerase (P) and X. There are three envelope proteins encoded by the S ORF, designated 
as large (preS1), middle (preS2), and major or small (S). They have a common carboxy-
terminus, but they differ at their amino-termini. The C ORF encodes the virus nucleocapsid 
protein carrying HBV core antigen (HBcAg) reactivity and a protein which, due to post-
translational modifications of HBcAg, displays e antigen (HBeAg) specificity. Transcription 
of the P ORF results in formation of a multidomain polypeptide with viral reverse 
transcriptase, RNase, and DNA polymerase activities which are essential for virus 
replication (Nassal, 2008; Wei et al., 2010). The X protein is derived from the smallest X ORF. 
It has transcriptional trans-activating properties and plays a role in virus oncogenicity. In 
terms of the replication strategy, the virus nucleocapsid migrates to the nucleus following 
entry and removal of envelope. There, HBV relaxed circular DNA (rcDNA) is converted to 
covalently closed circular DNA (cccDNA) by host DNA polymerases and ligases. This event 
is the first step in the viral replication cycle and detection of cccDNA serves as the marker of 
hepadnaviral replication. Four HBV mRNA transcripts, i.e., 3.5, 2.4, 2.1, and 0.7 kb, are 
transcribed from the cccDNA. The mature nucleocapsid particles containing rcDNA are 
either packaged into virions, which are exported from the cell, or recycled to the nucleus. 
HBV and related viruses, known as the hepadnaviral family, are the only DNA viruses that 
use reverse transcription in their replication cycle. 
In regard to pathogenicity, hepadnaviruses are considered to be essentially noncytopathic. 
Symptoms of hepatitis are a consequence of hepatocyte damage induced primarily by the 
host’s immune responses directed against viral peptides presented on infected cells in the 
context of major histocompatibility complex (MHC) molecules, particularly class I (Chisari 
& Ferrari, 1996; Michalak, 2004; Bertoletti et al., 2010; Chisari et al., 2010). The subsequent 
release of proinflammatory cytokines, such as interferon gamma (IFNγ) and tumor necrosis 
factor alpha (TNFα), by activated cytotoxic T cells (CTL) are the main mediators of liver 
injury (reviewed in Michalak, 2004; Bertoletti et al., 2010; Chisari et al., 2010). One of the 
unique characteristics of hepadnaviruses is their stealth nature during the incubation period 
with no evidence of T cell recognition for approximately two months after exposure. 
However, the data from the woodchuck model of hepatitis B indicate that immediately after 
invasion, WHV induces virus-nonspecific lymphocyte activation (Gujar et al., 2008), as well 
the cells of the innate immune system recognize virus shortly after its invasion, although 
they are not able to control virus replication or promptly induce virus-specific T cell 
responses (Guy et al., 2008a).  
One of the mechanisms of viral immune evasion, frequently utilized by viruses capable of 
long-term persistence, is their ability to infect immune cells (Alacami & Koszinowski, 2000). 
The lymphotropic nature of HBV has been shown in both in vivo and in vitro conditions 
(Korba et al., 1987; Blum et al., 1991; Chemin et al., 1992; Calmus et al., 1994; Michalak et al., 
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1994; Bläckberg & Kigg-Ljunggren, 2001; reviewed in Michalak 2000; Michalak et al., 2007; 
Pontisso et al., 2008; Coffin et al., 2011a, 2011b). On the other hand, the ability of WHV, 
which is a close relative of HBV, to infect and propagate in cells of the immune system has 
been well documented (Korba et al., 1988; Michalak et al., 1999; Michalak et al., 2004, 2007; 
reviewed in Michalak 2000, 2004; Mulrooney-Cousins & Michalak, 2007). Overall, 
hepadnaviruses have developed multiple mechanisms to avoid immune elimination 
allowing them to persist within an infected host independent of whether infection is 
symptomatic or clinically and serologically silent (occult). 
2. The woodchuck model of hepatitis B 
2.1 Woodchuck hepatitis virus (WHV) 
WHV was discovered in a colony of eastern North American woodchucks in the 
Philadelphia Zoological Garden, where a high rate of CH and HCC was observed (Summers 
et al., 1978). The WHV infection in this subspecies of woodchucks (Marmota monax) is 
acknowledged as the most accurate natural model for the study of the natural course of 
HBV infection, the pathogenesis of hepatitis B and HCC, as well as for preclinical 
evaluations of new antiviral agents and preventive methods against HBV. WHV and HBV 
share the same genome organization, significant antigenic cross-reactivity, the same range of 
targeted organs, and comparable sequelae of liver disease. Thus, both viruses cause hepatitis 
that progresses from acute hepatitis (AH) to CH and finally HCC (Summers & Mason, 1982; 
reviewed in Michalak, 1998, 2004; Menne & Tennant, 1999; Menne & Cote, 2007; Roggendorf 
et al., 2010). Nonetheless, the outbred nature of woodchucks and the relative shortage of 
WHV- and species-specific reagents and assays limit a wider utilization of the model. On the 
other hand, the woodchuck-WHV infection system is significantly more accessible and 
substantially less expensive than a chimpanzee model of hepatitis B, and liver disease and 
immunological processes in woodchucks are more closely compatible to a human disease 
situation than those in the avian models of HBV infection or in bioengineered mice. 
Considering the main differences between WHV and HBV-induced disease, HCC develops 
in almost all animals which have serum WHV surface antigen (WHsAg)-reactive CH 
(Popper et al., 1981; Korba et al., 1989). It is believed that the activation of cellular oncogenes, 
particularly c-myc and N-myc, through the integration of viral promoter sequences near 
these genes or through rearrangements of the genes, is responsible for the higher rates of 
HCC in woodchucks than in humans. However, WHV DNA can also integrate randomly 
into the hepatocyte genome, similarly to HBV DNA in human and chimpanzee hepatocytes 
(Feitelson & Lee, 2007; Mason et al., 2009). Another difference is that CH type B in humans 
frequently advances to cirrhosis, while this is not the case during CH in woodchucks. 
2.2 Serological and molecular markers of WHV infection 
The profile of serological markers of WHV infection closely mirrors that in HBV infection 
(Mulrooney-Cousins & Michalak, 2009). The detection of serum WHsAg is indicative of a 
high virus replication rate and persistence of WHsAg in the circulation for longer than 6 
months is indicative of CH, similarly to serum HBsAg in humans. In woodchucks that 
resolve AH, serum WHsAg falls to undetectable levels. However, concentration of plasma 
by ultracentrifugation may allow detection of WHsAg long after resolution of AH (Coffin et 
al., 2004). Further, antibodies to WHV antigens detectable in woodchucks also are similar to 
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their counterparts in HBV infection in terms of the time of their emergence, duration and 
diagnostic significance. Thus, antibodies to WHV core antigen (anti-WHc) are indicative of 
exposure to virus and, if they occur alone, they reflect the existence of occult WHV infection 
in which low levels of circulating WHV DNA can be also detected (Michalak et al., 1999; 
Coffin et al., 2004). In the case of HBV infection, the detection of IgM or IgG classes of anti-
HBc is indicative of a recent or a past exposure to the virus, respectively. However, 
identification of anti-WHc of IgM class is not yet routinely feasible in woodchucks. 
Antibodies to WHsAg (anti-WHs) are detectable after resolution of AH or seemingly 
asymptomatic infection and they confer protection from re-infection. However, as it will be 
explained later (Section 6.2), this is by no means an indication of total eradication of virus or 
normal liver histology. In recent years, the development of highly sensitive nucleic acid 
amplification assays detecting hepadnavirus DNA and its genome replicative intermediates, 
such as cccDNA and mRNA, have led to the delineation of new forms of hepadnaviral 
infection. These findings will be summarized below (Sections 6.2 and 6.3). The detection of 
WHV genome and serological (immunovirological) markers in different stages and forms of 








DNA     
Serum 
WHV DNA    
Immune cells* 
WHV 





- + - + + + or - 
Acute serologically 
apparent infection 
+ + - + + + 
Chronic serologically 
apparent infection 
+ + - + + + 
Secondary occult 
infection (SOI) 
- + + or - + + + 
Primary occult 
infection  (POI) 
- - - + + -  ** 
*  Based on WHV DNA detection in peripheral blood mononuclear cells (PBMC). 
** Low levels of WHV DNA and its replication intermediates can be detected after 3 or more years of 
follow-up of POI (Mulrooney-Cousins et al., manuscript in preparation). 
Table 1. Serological markers of WHV infection and WHV DNA detection in serum, cells of 
the immune system and liver as detected by research assays in various stages and forms of 
WHV infection 
3. Liver biopsy acquisition and histological grading of WHV hepatitis  
The significant advantage of the woodchuck model is access to serial liver biopsies from 
virologically and immunologically well-defined stages of infection, including samples prior 
to initiation of infection experiments which are essential for base line measurements. In 
addition, due to the size of the woodchuck liver, a sufficient amount of tissue can be secured 
via laparotomy for both diagnostic and experimental purposes, including isolation of 
hepatocytes and intrahepatic immune cells. In this laboratory, the protocols for collection of 
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liver biopsies and preservation of liver tissue samples from woodchucks are highly 
standardized. Briefly, animals are immobilized under general inhalant anaesthesia in a 
surgical suite under aseptic conditions. Liver tissue fragments (2-3 if required) are obtained 
by surgical laparotomy using a 7-mm wide-edge Schmeden No. 2 triangular punch 
(Churchill & Michalak, 2004). The liver bleeding is stopped with sterile absorbant hemostat 
cellulose (Surgicel; Ehicon Inc., USA). The tissue sample is divided into at least 3 portions. 
One is snap frozen in liquid nitrogen for nucleic acid isolations, another fixed in 10% 
buffered formaldehyde for histological examination, and a third cryopreserved for 
immunohistochemical investigations (Michalak, 1978). Depending on the nature of the 
experiment, small tissue fragments are also preserved for ultrastructural and other 
investigations.  
Histological examination of hepatic tissue remains the gold standard for determining the 
dynamic of progression of liver damage in viral hepatitis. Woodchuck liver specimens are 
processed exactly as those from patients. Thus, formalin-fixed tissue is embedded in 
paraffin and thin serial sections (4 µm) are stained with hematoxylin-eosin (H&E), Masson 
trichrome, periodic acid-Schiff and impregnated with silver. Upon double-blinded 
microscopic analysis, morphological alterations encountered in hepatocellular, 
extrahepatocellular intralobular and portal compartments of hepatic parenchyma are 
graded on a numerical scale from 0 to 3. The overall grade of disease severity from 0 to 3 
with 0.5-score intervals, defined as histological degree of hepatitis, is assigned taking into 
consideration the grades given for each category of liver lesions and the global impression 
on the pathological picture as a whole (Michalak et al., 1990, 1999, 2000). The pivotal 
significance of histological examination in uncovering new aspects of natural history of 
hepadnaviral infection has been illustrated when serial liver biopsies obtained over the 
lifespan of woodchucks convalescent from AH were analyzed. It was found that although 
the animals cleared serum WHsAg, mounted anti-WHs and normalized liver enzymes, they 
persistently carried low levels of replicating virus and their livers showed an intermittent 
minimal to moderate liver inflammation up to the end of their lives. This documented that 
liver lesions did not subside completely despite apparent complete serological and 
biochemical resolution of hepatitis. Importantly, approximately 20% of the animals 
ultimately developed HCC (Michalak et al., 1999). This finding was consistent with a similar 
observation made by others (Korba et al., 1989). Accumulating clinical evidence indicates 
that the same may happen in humans convalescent from an episode of self-limited AH 
(Pollicino et al., 2004; Simonetti et al., 2010).  
4. Isolation of hepatocytes from liver biopsy 
Hepatocytes are the site of the most robust virus replication in serologically evident, 
symptomatic hepadnaviral infection. However, during the pre-acute phase and in the course 
of persistent low level WHV infection continuing after recovery from AH, termed as 
secondary occult infection (SOI) (see Section 6.3), the levels of WHV replication are 
comparable in hepatocytes and in infected immune cells (Michalak et al., 1999, 2004). Up to 
this point, it has been virtually impossible to mimic the vigorous HBV or WHV replication 
seen in vivo in cell culture systems. It is for this reason that the derivation of primary 
hepatocytes from liver biopsies or during autopsy and establishment of cell lines from them 
are valuable tools in the attempts to understand hepatocyte engagement in different forms 
of hepadnaviral infection, to uncover mechanisms of hepadnaviral cell-to-cell spread and to 
assess hepadnavirus influence on hepatocyte function on the single cell level. 
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In most instances, primary hepatocytes can be isolated by microperfusion with a collagenase 
buffer under aseptic conditions from as little as 100-150 mg of liver tissue (Churchill & 
Michalak, 2004). After gentle teasing of the cells through a sieve, the cells are collected by 
low-speed centrifugation and are extensively washed until a high purity preparation of 
hepatocytes (>97%) is obtained. Cells are allowed to attach in culture flasks for 4 hours and 
after culture for 24 hours, hepatocytes from virus-naïve animals can be exposed to WHV for 
infection experiments, whereas those from WHV-infected woodchucks examined for viral 
genome and protein expression and/or used for assessing antiviral potential of test agents 
(Churchill & Michalak, 2004). Using this approach, a hepatocyte cell line, designated as 
WCM-260, was established from liver biopsy of a healthy woodchuck (Churchill & 
Michalak, 2004). The hepatocyte origin of the line was confirmed by gene expression 
analysis and identification of proteins specifically produced by hepatocytes. The studies 
carried out using this cell line significantly contributed to recognition of different aspects of 
WHV and hepatocyte biology, including studies on WHV cell tropism (Lew & Michalak, 
2001; Mulrooney-Cousins & Michalak, 2008), hepadnavirus effect on the class I MHC 
expression (Wang et al., 2006), mechanisms of hepatocyte cytotoxicity and their modulation 
by hepadnaviral infection (Guy et al., 2010, 2011). 
5. WHV-cell interactions in vitro 
The WCM-260 hepatocyte line was found to be susceptible to WHV infection, regardless of 
whether the WHV inoculum was derived from serum of WHV-infected woodchucks or 
from in vitro infected hepatocytes or lymphocytes (Lew & Michalak, 2001; Mulrooney-
Cousins & Michalak, 2008). WHV obtained after serial passage in WCM-260 cells caused 
classical AH in virus-naïve woodchucks (Lew & Michalak, 2001) and the virus genome 
sequence remained unchanged after multiple passages (Mulrooney-Cousins & Michalak, 
2008), indicating that the cells supported replication of the biologically competent virus 
under conditions favorable to virus growth.  
Although hepatocytes and lymphoid cells are known targets of WHV and HBV, there is still 
very little knowledge in regard to the receptor/s mediating the highly restricted cell tropism 
characterizing these viruses. However, it has been shown that there is a protease-activated 
cell recognition site in the preS1 (large) protein of WHV that mediates strictly host-specific 
binding to woodchuck hepatocytes and lymphoid cells (Jin et al., 1996). The crucial 
determinant of this site was mapped to amino acids 10-13 at the amino-terminus of the large 
envelope protein. Synthetic peptides comprising the site sequence bound woodchuck 
hepatocytes and lymphoid cells with characteristics of a specific ligand-receptor interaction, 
although their ability to interact with lymphocytes was significantly greater (approximately 
1000-fold) than that for hepatocytes. Interestingly, this binding site was protected within the 
tertiary structure of the virus preS1 envelope protein and was not identifiable unless the 
protein was treated with proteases. When animals experimentally infected with WHV were 
examined for the presence of antibodies directed against the site, the antibodies were found 
to appear as the first immunological indicator of virus infection, suggesting that proteolytic 
cleavage of the preS1 protein also occurs in vivo (Jin et al., 1996). 
6. Findings regarding natural history  
Much of our understanding regarding the natural history and pathogenesis of HBV 
infection has come from investigations of the woodchuck-WHV model. The subsequent 
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sections will be focused on new aspects of the natural history of hepadnaviral infection that 
have come to light by analyzing the liver and other natural compartments of WHV 
replication in woodchucks experimentally infected with various virus doses. 
6.1 Symptomatic serologically evident hepadnaviral infection 
The transmission of WHV through blood and body fluids, as well as vertically from mother 
to offspring, parallels that of HBV. Most neonates infected with WHV before 3 days after 
birth or those born to mothers with serum WHsAg-positive infection develop serologically 
evident CH that almost invariably progresses to HCC. This suggests that the maturity of the 
immune system at the time of infection is an important element determining establishment 
of CH. The role of virus dose and a possible influence of virus strain in the rate of CH 
development have been considered (Cote et al., 2000a, 2000b; Michalak et al., 2004). In adult 
animals, serum WHsAg-positivity accompanied by AH is usually self-limiting and is 
followed by the apparent complete antigen clearance; however molecular indicators of 
residual WHV infection remain (Michalak, 1998; Michalak et al., 1999, 2004; reviewed in 
Michalak, 2000, 2004; Guy et al., 2008a). The same happens in patients with self-limited AH 
(Michalak et al., 1994; Grob et al., 2000; Marusawa et al., 2000; Chemin et al., 2001; Murakami 
et al., 2004; De Mitri et al., 2010; Raimondo et al., 2010). Similarly, approximately 10% of 
serum WHsAg-positive adult woodchucks and 5-10% of serum HBsAg-positive humans 
develop CH. However, suppression of the immune responses by administration of 
cyclosporin A dramatically increases the rate of progression to CH in experimentally 
infected woodchucks (Cote et al., 1992). This supports the concept that the competence of the 
immune system plays a pivotal role in CH development.  
Lymphotropism is an inherent property of many viruses capable of establishing persistent 
infection (Alcami & Koszinowski, 2000). There is a long history of findings indicating that 
both HBV and WHV can persist and actively replicate at extrahepatic locations, specifically 
in the cells of the lymphatic (immune) system, in the course of serologically evident chronic 
infection (Pontisso et al., 1984, 2008; Yoffe et al., 1986; Korba et al., 1987, 1988; Ogston et al., 
1989). Studies in the woodchuck model significantly contributed to identification of 
hepadnavial lymphotropism and characterization of virus replication in cells of the immune 
system. Overall, although WHV replicates at approximately 50 to 100-fold lower levels (per 
cell) in immune cells than in hepatocytes in chronic symptomatic infection, the size of the 
reservoir is very large considering the total number of cells which constitute the immune 
system.  
Hepadnavirus clearance without massive immune-mediated destruction of infected 
hepatocytes occurs in both HBV and WHV infections (Guidotti et al., 1999; Guidotti & 
Chisari, 2001). In one study, hepatocytes were labeled during the peak of AH, when nearly 
all liver cells are infected (Kajino et al., 1994). After immunohistochemically evident 
elimination of WHV antigens from the liver, many labeled hepatocytes were still present, 
suggesting that non-cytopathic viral clearance occurs in infected woodchucks. Other studies 
investigating the role of anti-viral cytokines, such as IFNγ and TNFα, as determinants of 
progression of AH to CH or recovery, demonstrated that the hepatic cytokine milieu during 
the acute phase of infection is important in determining the outcome of hepatitis in both 
neonatally acquired and adult WHV infections (Cote et al., 2000b; Hodgson and Michalak, 
2001). Thus, elevated intrahepatic levels of IFNγ, TNFα, and CD3 expression, together with 
a lower hepatic viral load and augmented liver inflammation, preceded recovery from AH, 
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while the opposite coincided with progression of AH to CH (Hodgson & Michalak, 2001). 
Although cells of the innate immune system sense WHV within the liver as early as an hour 
after intravenous injection of virus and cause a significant decrease in virus hepatic load 
within 3 hours post-inoculation, this response is impaired and unable to eliminate virus or 
promptly induce effective anti-virus T cell response (see Section 9) (Guy et al., 2008a). 
Symptomatic hepatitis B is commonly accompanied by autoimmune phenomena clinically 
appearing as circulating organ non-specific and organ-specific autoantibodies. Although the 
pathogenic relevance of these responses to liver injury remains unclear in humans, it is 
generally accepted that their presence coincides with a more severe course of hepatitis 
(Poralla et al., 1991; Cacoub & Terrier, 2009). In the woodchuck model, WHV infection 
usually induces organ non-specific autoantibodies, such anti-smooth muscle antibodies 
(SMA) and anti-nuclear antibodies (ANA) (Dzwonkowski & Michalak, 1990), as well as 
liver-specific antibodies directed against hepatocyte asialoglycoprotein receptor (ASGPR) 
(Diao & Michalak, 1996, 1997). It has been found that circulating autoantibodies to ASGPR 
(anti-ASGPR) induced by WHV infection are capable of causing complement-mediated lysis 
of hepatocytes and inhibit binding of desialylated glycoproteins to hepatocyte ASGPR, 
which mediates their clearance (Diao et al., 1998). It has been also shown that the induction 
of anti-ASGPR prior to infection with a liver pathogenic dose of WHV tended to modulate 
infection toward CH outcome, and that the occurrence of anti-ASGPR in woodchucks with 
ongoing CH was associated with exacerbated histological severity of hepatitis. These 
findings raised the possibility that the liver compromised by CH might be prone to anti-
ASGPR directed complement-mediated hapatocellular injury due to formation of the 
ASGPR-anti-ASGPR immune complexes at hepatocyte plasma membranes (HPM) (Diao et 
al., 2003). Based on these findings, it is expected that the host’s immune response mounted 
against ASGPR may contribute to both the outcome and the severity of hepadnaviral 
hepatitis (Diao et al., 1998, 2003).  
6.2 Primary occult WHV infection 
Primary occult infection (POI) was originally identified in offspring born to woodchuck 
dams convalescent from AH, including those which developed anti-WHs antibodies after 
an episode of serum WHsAg-positive infection (Coffin & Michalak, 1999). All offspring 
from these dams demonstrated low levels of WHV genomes and WHV cccDNA and 
mRNA in the lymphatic system, while the liver was infected only in some of them. 
Importantly, no serological markers of infection, such as WHsAg, anti-WHc or anti-WHs, 
could be detected. In addition, WHV DNA-reactive particles displaying biophysical 
characteristics of complete virions were found in the circulation of the offspring. Thus, 
they migrated with comparable velocity in sucrose and had the buoyant density of intact 
WHV virions. Histological examination of serial liver biopsies showed normal liver 
morphology in all animals. Furthermore, the inocula prepared from serum or 
supernatants of cultured lymphoid cells acquired from these offspring induced 
serologically evident WHV infection and hepatitis in virus-naive adult animals, 
confirming the pathogenic competence of the virus. Interestingly, the offspring were not 
protected from challenge with a liver pathogenic dose of WHV (i.e., 1.1 x 1010 vge), 
indicating that this low level infection did not induce virus-specific protective immunity 
(Coffin & Michalak, 1999). This study was the first to identify that hepadnaviral infection 
can be restricted to the lymphatic system and does not engage the liver, indicating that at 
low infectious doses hepadnavirus could be primarily lymphotropic.  
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This finding was followed by another study in which the amount of WHV required to 
establish serologically silent, lymphatic system-restricted infection was determined using 
intravenous inoculations of woodchucks with serial 10-fold dilutions of a well characterized 
WHV inoculum (Michalak et al., 2004). The WHV genome was detected in the circulation 
and its replicative intermediates in cells of the immune system but not in the liver, while 
anti-viral antibodies were consistently absent. The liver biopsies collected from these 
animals over 3 years of follow-up showed normal morphology. The study not only 
confirmed the existence of POI and uncovered that this form of infection is induced by virus 
doses lower than 103 virions, but also established a reproducible model of POI. In the same 
study, it was uncovered that the inoculum that induced POI at doses greater than 103 virions 
caused classical serum WHsAg-positive AH. Taken together, the results from this study 
revealed that the amount of invading virus determines whether infection is serologically 
apparent or silent, that only virus doses greater than 103 virions are liver pathogenic, and 
that the cells of the lymphatic system are primary targets when virus invade a susceptible 
host at small doses (<103 virions) (Michalak et al., 2004). 
Currently, the long-term pathological consequences of POI are under investigation. In this 
regard, liver biopsies collected at approximately yearly intervals from animals followed for 
over 5 years are examined for virus presence and morphological alterations. During this 
observation period, all animals showed molecular evidence of WHV infection in the absence 
of the infection serological markers. As expected, the infection was restricted to the 
lymphatic system. However, after approximately 3 years post-infection, WHV DNA and 
WHV mRNA became detectable in the liver, even though viral load in serum of these 
animals rarely exceeded 100 vge/mL. The pathogenic competence of the persisting virus 
was documented by demonstrating its ability to induce classical AH in virus-naïve animals. 
This ability was observed regardless of whether serum was collected at the time of 
lymphatic system-restricted infection or when infection also involved the liver (Mulrooney-
Cousins et al., manuscript in preparation). Liver histology remained normal up to 4 years 
post-infection. However, minimal necroinflammatory alterations were found after 5 years 
post-infection. The most important finding was that HCC had developed in some of the 
animals, indicating that the persisting virus retained its oncogenic potency and, therefore, 
that this form of infection is of a direct pathological relevance (Mulrooney-Cousins et al., 
manuscript in preparation). In another study, intrahepatic injection of small amounts of 
recombinant complete WHV DNA has also induced POI, whereas high doses of the same 
WHV DNA similarly administered can induce typical AH (Will et al., 1982; Chen et al., 1998; 
Mulrooney-Cousins & Michalak, manuscript in preparation). 
The characteristics of WHV-specific T cell immune responses and cytokine expression 
profiles in circulating lymphoid cells were also examined in the course of experimental POI 
and subsequent challenge with liver pathogenic dose (>103 virions) or liver non-pathogenic 
dose (50 virions) of the same inoculum (Gujar & Michalak, 2009). The data revealed that POI 
was accompanied by the appearance of a strong WHV-specific T cell proliferative response 
directed against multiple viral epitopes which intermittently persisted at low levels for up to 
10 months of follow-up. Moreover, immediately after exposure to a liver-nonpathogenic 
dose of WHV, lymphocytes acquired a heightened capacity to proliferate in response to 
mitogenic stimuli and displayed augmented expression of IFNα, interleukin-12 (IL-12) and 
IL-2, but not TNFα and the profile of that response was closely comparable to that seen in 
infection induced with liver-pathogenic viral doses (Gujar et al., 2008; Gujar & Michalak, 
2009). The data also showed that virus-specific T cell proliferative reactivity is a very 
www.intechopen.com
 
Liver Biopsy in Modern Medicine 
 
364 
sensitive indicator of exposure to hepadnavirus, even to very small amounts that induce 
serologically silent infection. They demonstrated that POI is not only identifiable 
molecularly but it is also a distinctive immunological entity.  
The existence of POI in humans has not yet been clearly established, however existence of 
HBV-specific CD8+ T cell response in the absence of HBV-specific antibodies and the 
presence of detectable HBV DNA (Zerbini et al., 2008), strongly suggest that this form of 
infection may occur. On the other hand, the consequences of HBV infection in infants born 
to mothers with resolved hepatitis B have never been investigated. One of the constraints in 
this type of study is the difficulty in acquisition of serial samples from different 
compartments of virus occurrence, i.e., serum or plasma, lymphoid cells (PBMC) and liver, 
and their proper standardized preparation to secure recovery of small amounts of viral 
material. Another important limitation is the sensitivity of the clinical assays currently 
applied for detection of HBV genome, which are at least 100-times less sensitive than the 
research assays applied for this purpose. The strong similarities between WHV and HBV 
suggest that the persistence of small amounts of the virus could have a significant impact in 
terms of transmission of infection and pathogenesis of disorders which are not yet 
considered to be a consequence of persistent hepadnavirus infection. POI initiated by 
minute amounts of the virus transmitted from mothers may induce occult infection in 
neonates, similar to the chronic infection induced in newborns to mothers with symptomatic 
CH (Beasley, 2009). Also, transmission of virus from unknowingly HBV infected individuals 
via blood transfusion and organ donation remains a relative risk until clinical laboratory 
assays reach a sensitivity that is now only obtained by research assays (Lok et al., 1991; 
Uemoto et al., 1998; Conjeevaram & Lok, 2001; Mulrooney-Cousins & Michalak, 2007, 2009; 
De Mitri et al., 2010; Schmeltzer & Sherman, 2010).  
6.3 Secondary occult hepadnaviral infection  
Residual hepadnaviral infection continuing after resolution of HBV and WHV hepatitis, i.e., 
secondary occult infection or SOI, have been documented in both humans and woodchucks 
(Liang et al., 1990; Blum et al., 1991; Mason et al., 1992, 1998; Michalak et al., 1994; Michalak et 
al., 1999; Michalak, 2000; Bläckberg & Kidd-Ljunggren, 2001; Mulrooney-Cousins & 
Michalak, 2007; Tong et al., 2009; Gerlich et al., 2010; Hollinger & Sood, 2010; Raimondo et al., 
2010; Lledo et al., 2011; Said, 2011). It is now evident that the anti-viral immunity established 
after an encounter with WHV or HBV at doses that cause hepatitis is not able to completely 
eradicate the virus and replication of virus persists in both hepatocytes and cells of the 
lymphatic system (Chemin et al., 1992, 1993; Michalak et al., 1994, 1999; Cabrerizo et al., 2000; 
Mulrooney & Michalak, 2003; Murakami et al., 2004). In this form of infection, the virus can 
persist for many years without apparent variations in its sequence or emergence of cell type-
specific mutants (Laskus et al., 1999; Bläckberg & Kidd-Ljunggren, 2001; Mulrooney-Cousins 
& Michalak, 2008). 
In the woodchuck model, persistence of WHV replication and production of small amounts 
of infectious virions after resolution of self-limiting AH is life-long when highly sensitive 
PCR-based assays coupled with detection of amplicons via nucleic acid hybridization 
(PCR/NAH) are used (Michalak et al., 1999). This life-long carriage involves the liver and is 
not restricted to the lymphatic organs and PBMC like in POI. As already mentioned (Section 
3), animals that have serologically resolved AH show transient minimal to moderate liver 
inflammatory alterations through their lifespan (Michalak et al., 1999), as has also been 
reported for individuals with self-limited AH type B (Yuki et al., 2003). Moreover, up to one 
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fifth of the recovered animals develop HCC (Michalak et al., 1999). Taken together, virus 
persisting at very low levels as SOI retains its liver pathogenic and oncogenic potentials.  
SOI is always accompanied by anti-WHc and frequently by anti-WHs (Michalak et al., 1999; 
Michalak et al., 2007). It has also been shown that the persistence of isolated anti-WHc is 
indicative of SOI, even in the absence of prior evidence of serologically evident, i.e., serum 
WHsAg reactive infection (Coffin et al., 2004). In such animals, low levels of WHV DNA are 
detectable in the serum, PBMC and liver by PCR/NAH (Coffin et al., 2004). This form of 
infection is also accompanied by the persisting ability of T cells to respond to virus-specific 
stimuli (Gujar et al. 2008), which also characterize T cell proliferative and cytotoxic responses 
in patients with a past history of self-limiting AH (Rehermann et al., 1995, 1996a, 1996b; 
Penna et al., 1996). 
The importance of SOI has also been highlighted in the study in which woodchucks were 
immunized with a bicistronic DNA vaccine carrying WHV core and woodchuck IFNγ in an 
attempt to enhance induction of protective immunity against virus. It has been postulated 
that the immunity elicited against nucleocapsid of HBV or WHV could be important in 
treatment of CH and protection from infection (Murray et al., 1987; Garcia-Navarro et al., 
2001). It was found that the animals receiving high doses of the vaccine successfully 
produced anti-WHc (Wang et al., 2007). However, molecular analysis of liver biopsies 
revealed that although the animals were protected from hepatitis, as confirmed by 
histological examination, they were not entirely sheltered from WHV infection since WHV 
DNA and RNA remained detectable in the livers at levels comparable to those seen in SOI. 
The results implied that vaccination with DNA encoding hepadnaviral core protein may not 
be sufficient to mount sterilizing immunity against the virus or prevent establishment of 
occult infection, although it can protect against development of symptomatic hepatitis.  
7. WHV-hepatocyte plasma membrane interactions in the course of hepatitis 
As already indicated, the development of hepadnaviral hepatitis is a direct consequence of 
the cytopathic immune responses directed against infected hepatocytes. However, minimal 
inflammatory alterations or their absence and essentially normal liver function tests are 
observed in patients with very high hepatic loads of HBV envelope material where 
essentially all hepatocytes carry the antigen, as is observed in a healthy chronic HBV carrier 
state. This and other observations raised questions as to whether there is a relationship 
between the status of hepadnaviral protein incorporation into HPM structure and 
immunomorphological forms of hepatitis. This was based on the postulate that 
hepadnaviral proteins exposed on hepatocytes can modulate immunopathogenic reactions 
causing liver damage. In a series of studies, highly purified HPM isolated from woodchucks 
with different stages of WHV hepatitis or HCC were analyzed for the amounts of the HPM-
associated WHV proteins, the protein molecular profiles and the nature of their association 
with the HPM bilayer. Comparative analysis revealed that the HPM levels and molecular 
profiles of WHV nucleocapsid (core) protein were not related to the duration or histological 
severity of liver damage. In contrast, quantities of the virus envelope material (WHsAg) 
were significantly greater in HPM derived from CH than from AH or HCC. Interestingly, 
although the envelope preS1, preS2 and S polypeptides were detected in all infected HPM, 
expression of WHV pre-S2 polypeptides was always dominant (Michalak & Lin, 1994) (also 
see Section 8). Furthermore, in CH, WHV envelope proteins was found to be very tightly 
bound to HPM and behaved as integral membrane proteins, implying its irreversible 
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incorporation into the plasma membrane structure and suggesting that they could be 
eliminated only by lysis of infected hepatocytes (Michalak & Churchill, 1988). In addition, 
HPM from woodchucks with CH or from nontumor parenchyma of animals with HCC, but 
not HPM from AH or healthy animals, showed an inability to bind an exogenous WHsAg 
(Michalak & Lin, 1994). The same was also observed for plasma membranes purified from 
livers of chronic carriers of WHV with minimal hepatitis (Michalak, 1988). Taken together, 
the extent and the characteristics of WHV envelope interaction with HPM undergo 
significant variations in the natural course of hepatitis and distinct forms of WHV-induced 
liver disease display specific properties of that association. The accumulation of WHV 
envelope proteins in HPM is a prominent characteristic of CH, but is not connected with 
histological activity of liver inflammation (Michalak et al., 1990). This event may contribute 
to the maintenance of chronic disease by creating an immune resistant barrier preserving 
infected hepatocytes. In this regard, the augmented display of WHV envelope proteins, 
particularly pre-S2 peptides, in CH coincides with a significant inhibition of class I MHC 
display on hepatocyte surface. This may profoundly impact the effectiveness of the 
elimination of infected hepatocytes by virus-specific CTL (Michalak et al., 2000). 
It should also be noted that anti-WHc and antibodies recognizing WHV e antigen (anti-
WHe) reactivity were also detected in association with HPM (Michalak et al., 1990). 
However, while anti-WHc antibodies were readily identifiable, anti-WHe could only be 
detected in eluates from HPM of animals that had recovered from AH (Michalak et al., 1990). 
This suggested that a humoral response against e antigen may contribute to the resolution of 
acute infection, presumably by the elimination of infected hepatocytes through antibody-
mediated cytolysis, as was suggested for chimpanzees vaccinated with HBeAg (Schlicht et 
al., 1991).  
8. WHV inhibition of hepatocyte class I MHC in chronic hepatitis  
As previously mentioned, the utilization of such a unique animal model as the WHV-
infected woodchucks has certain disadvantages; they are, among others, related to the lack 
of commercially available reagents and assays. This laboratory has made a significant effort 
over the years in developing tools essential for research on different aspects of hepadnaviral 
infection, and the liver and the immune system biology in this model. One of the important 
antibodies generated was a monoclonal antibody (mAb) against the heavy chain of 
woodchuck class I MHC (Michalak et al., 1995). Employment of this woodchuck-specific 
mAb, as well as flow cytometry and immunoblotting analyses, revealed that normal 
woodchuck hepatocytes express class I MHC, although at a low level, in contrast to the 
previous assumptions based on immunohistochemical staining. With this new tool in hand, 
class I MHC expression was examined on hepatocytes and HPM isolated from different 
stages of experimentally induced WHV hepatitis (Michalak et al., 2000). It was found that 
AH is characterized by a significantly enhanced hepatocyte surface display of class I MHC. 
This coincided with the augmented hepatocyte gene expression for class I MHC heavy 
chain, IFNγ and class I MHC-associated genes, such as ß2-microglobulin and transporters 
associated with antigen processing (TAP1 and TAP2). However, despite the similarly 
augmented transcription of class I MHC heavy chain and the associated genes in 
hepatocytes from woodchucks with CH, there was no evidence of class I MHC protein 
presence on the hepatocyte surface. This indicated a profound posttranscriptional inhibition 
in the class I MHC display in hepatocytes chronically infected with WHV (Michalak et al., 
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2000). Since, the cell surface class I MHC is paramount to the efficient presentation of viral 
peptides to virus-specific CTLs, this finding was of high importance to our understanding of 
mechanisms underlying development and perpetuation of CH in hepadnaviral infection.  
Further investigations have focused on the elucidation of which of the WHV proteins are 
specifically responsible for the inhibition of class I MHC display on hepatocytes (Wang & 
Michalak, 2006). In this study, WCM-260 hepatocytes (see Section 4) transfected with 
WHV genes encoding individual viral proteins as well as the entire WHV genome were 
employed. It was found that hepatocyte presentation of class I MHC was significantly 
inhibited following transfection with the complete WHV genome or with viral 
subgenomic fragments encoding envelope preS2 (middle) or preS1 (large) protein, which 
also encompasses the preS2 amino acid sequence. In contrast, hepatocytes transfected 
with the WHV X gene demonstrated a significant augmentation in the class I MHC 
protein display. Further, treatment of hepatocytes with recombinant woodchuck IFN-γ 
(Wang & Michalak, 2005) restored the inhibited presentation of the class I antigen induced 
by total WHV and preS2 and preS1 sequences.  It is of note that the class I antigen 
suppression was not associated with down-regulation of hepatocyte genes for class I 
MHV heavy chain, ß2-microglobulin, TAP1, TAP2 and proteasome subunits. Taken 
together, these findings indicated that the defective presentation of class I MHC on 
hepatocytes transcribing WHV is a consequence of posttranscriptional suppression 
exerted by the virus pre-S2 envelope protein and that this defect can be fully reversed by 
treatment with IFNγ (Wang & Michalak, 2006).     
9. Intrahepatic immune response in pre-acute WHV infection  
One of the impediments to understanding the pathogenesis of HBV infection is the lack of 
the delineation of virological and immunological events occurring in the liver immediately 
after hepadnavirus invasion and during the pre-acute phase of infection, since identification 
of patients in during this asymptomatic phase of infection is extremely difficult and 
acquisition of liver biopsy material is practically impossible due to the lack of clinically 
sound indications. For these types of investigations, the woodchuck model of hepatitis B is 
particularly well suited. Using woodchucks with experimentally induced AH, the hepatic 
kinetics of hepadnavirus replication and the profiles of activated genes encoding cytokines, 
cytotoxic effector molecules and immune cell markers were quantified in sequential liver 
biopsies from one hour post-inoculation outward using real-time amplification assays (Guy 
et al., 2008a). To achieve the most complete recognition of the events investigated, over 110 
liver biopsies were collected starting from the time when animals were healthy to up to 36 
months after virus infection when SOI was established. The study showed that WHV 
replication is detectable in the liver within one hour after infection. In 3 to 6 hours, 
significantly augmented hepatic transcription of IFNγ and IL-12 were evident, implying 
activation of antigen presenting cells. In 48 to 72 hours, natural killer (NK) cells and NK T 
cells were activated and WHV replication was transiently but significantly inhibited, 
indicating that this early innate immune response is at least partially successful in limiting 
virus propagation in the liver. Despite this, T cells were activated 4 to 5 weeks later when 
hepatitis became histologically apparent. Overall, these data demonstrated that 
hepadnaviral replication is initiated and the innate response is activated in the liver soon 
after exposure to a liver pathogenic dose of virus. Nonetheless, this response is unable to 
prompt a timely virus-specific T cell reactivity which is a characteristic of infections with 
other viral pathogens (Guy et al., 2008a).  
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10. New insights into hepatocyte function 
It is now acknowledged that the liver plays an important role in immunity, particularly in 
maintenance of peripheral tolerance and pathogen surveillance. Although the involvement 
of liver cells, such as Kupffer cells and sinusoidal endothelial cells, is relatively well 
recognized (Bertolino et al., 2002; Warren et al., 2006; Crispe, 2009), a contribution of 
hepatocytes to the intrahepatic immunological process was entirely unknown. By using 
woodchuck and human primary hepatocytes, as well as woodchuck WCM-260 hepatocyte 
line, novel and unexpected properties of hepatocytes were uncovered (Guy & Michalak, 
2008). 
10.1 Hepatocyte as cytotoxic effector cells 
Initially, in contrast to the previous opinion, it was found that normal primary and cultured 
hepatocytes constitutively express CD95 ligand (CD95L, formerly called Fas ligand) and are 
capable of inducing death of CD95-bearing cells (Guy et al., 2006). Cytokines, such as IFNγ 
and TNFα, can upregulate hepatocyte expression and usage of CD95L. Then, we also 
documented that hepatocytes express perforin and can kill cells brought into contact with 
their surface via an exocytic pathway. However, this cytotoxic potency of hepatocytes is not 
modified by the cytokine milieu (Guy et al., 2008b). We concluded that hepatocytes, similar 
to lymphocytes, are endowed in two distinct cytotoxic effector mechanisms. The relevance 
of these findings may pertain not only to fratricidal cell death during the development and 
progression of liver disease, but implicate an active cytotoxic role for hepatocytes as they 
may interact with other cells either trafficking through or residing in the liver. In this regard, 
our recent study showed that hepatocytes are capable of eliminating activated autologous T 
lymphocytes utilizing both CD95-CD95L and perforin-granzyme B dependent pathways 
(Guy et al., 2011). Despite that the ability of hepatocytes to eliminate contacted cells was 
documented and the underlying cytopathic mechanisms were delineated, it remained 
unknown whether hepatocyte-mediated cell killing is indiscriminant or if hepatocytes are 
capable of discerning which cells are to be eliminated. Furthermore, the cell surface 
molecules involved in hepatocyte recognition of cells targeted for killing were recently 
investigated. In the course of this study, it was identified that the hepatocyte specific 
protein, ASGPR (as mentioned already in Section 6.1), which plays a central role in the 
clearance of circulating desialylated glycoproteins, is involved in the recognition and 
removal of cells by hepatocytes (Guy et al., 2011).     
10.2 WHV infection augments hepatocyte cytotoxicity 
To recognize if hepadnaviral infection modifies the cytotoxic potency of hepatocytes, we 
investigated primary hepatocytes isolated from woodchucks with progressing CH and those 
which resolved AH (Guy et al., 2010). It was found that the hepatocyte potential to kill 
contacted cells is significantly augmented both during CH and after resolution of AH when 
compared to hepatocytes from healthy animals. Furthermore, hepatocytes exposed to 
exogenous IFNγ, but not those transfected with the complete WHV genome or individual 
virus genes, except the WHV X gene, demonstrated enhanced CD95L and perforin-mediated 
cytotoxicity. This argued that augmented intrahepatic production of IFNγ rather than virus 
replication itself increased the killing. In this regard, an increased intrahepatic expression of 
IFNγ was reported not only in CH but also during SOI continuing after resolution of AH 
(Hodgson & Michalak, 2001). It was also observed that hepatocytes transfected with the 
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WHV X gene alone transcribed significantly more CD95L and perforin and killed cell targets 
more efficiently, suggesting that under certain circumstances, albeit probably very rare, the 
virus may directly augment hepatocyte cytotoxicity (Guy et al., 2010). This was the first 
study that demonstrated that the cytotoxic phenotype of hepatocytes can be modified by 
virus infection and that this occurred irrespective whether liver inflammation is active or 
progresses quiescently. Although hepatocyte cell killing may not be apparent in the normal 
liver, it is reasonable to expect that inflammation and other forms of liver damage may 
heighten the ability of hepatocytes to cause death of other cells residing or passing through 
the liver and, in consequence, influence progression and outcomes of diseases engaging this 
organ (Guy et al., 2008). 
11. Conclusions 
Liver biopsy material is invaluable for determination of the progression of viral hepatitis 
and assessment of the outcome of antiviral therapy, as well as for investigations into the 
pathogenesis of hepatocellular injury and perpetuation of hepatitis. Many of the 
mechanisms of liver disease, the elements of the natural course of hepadnaviral infection, 
the basic biological properties of hepadnaviruses as well as hepatocyte biology were 
delineated by utilizing liver biopsy material from the woodchuck model of hepatitis B. This 
overcame impediments imposed by difficulties in obtaining hepatic tissue specimens from 
patients with different stages of hepatitis B and from seemingly healthy individuals with 
silently progressing infection. The ability to obtain sequential liver biopsies prior to and 
over the course of experimentally induced WHV infection has led to the discovery of 
previously unknown characteristics and consequences of hepadnaviral infection which are 
only recently being recognized in the clinical setting. The woodchuck-WHV infection model 
retains a significant potential to generate new knowledge which should be even more 
vigorously explored in years to come. 
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